OneSource Specialty Pharma Ltd

OneSource Specialty Pharma Ltd Share Price Today: Live Updates & Key Insights

Get insights on OneSource Specialty Pharma Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.

OneSource Specialty Pharma Ltd Share Price Chart

ONESOURCE at 10 Jul 2026 06:34 PM Pharmaceuticals

1626.90 +1.20(+0.07%)

Lowest Today 1506.10

Highest Today 1650.00

Today's Open 1626.10

Prev. Close 1625.70

52 Week High 2248.00

52 Week Low 1057.00

OneSource Specialty Pharma Ltd Fundamentals

Traded Volume: 9,60,506

Market Cap(Cr): 18,651.72

Avg Traded Price 1582.91

1 Year return %

Upper Circuit 1,650

Lower Circuit 1,506.1

P/E TTM -253.00

P/B Ratio 3.132

Traded Value(Cr) 15626.47

EPS TTM -6.436

Book value/Share 519.130

Dividend Yield 1Y 0.00%

OneSource Specialty Pharma Ltd Share Price Performance

Shows the percentage change in stock price over different time periods

This section highlights OneSource Specialty Pharma Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the OneSource Specialty Pharma Ltd share price history, short-term movements, long-term trends, and overall investor sentiment

1W -3.60%

1M -5.16%

3M +18.26%

1Y 0.00%

YTD -9.06%

OneSource Specialty Pharma Ltd Traded Volume Movement

Shows the trading volume over different time periods

This section highlights OneSource Specialty Pharma Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment

Yesterday 2.38L

Day Before Yesterday 4.00L

1W Avg 3.91L

1M Avg 2.41L

3M Avg 4.75L

OneSource Specialty Pharma Ltd Technical Details

OneSource Specialty Pharma Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.

Support 1 1539

Support 2 1450

Support 3 1395

Pivot Point : 1594

Resistance 1 1683

Resistance 2 1738

Resistance 3 1826

OneSource Specialty Pharma Ltd Corporate Actions

OneSource Specialty Pharma Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on OneSource Specialty Pharma Ltd’s capital allocation strategies.

All

Dividends

No Dividend has been declared by ONESOURCE

Bonus

No Bonus has been declared by ONESOURCE

Splits

No Split has been declared by ONESOURCE

Others

Rights No Rights has been declared by ONESOURCE

OneSource Specialty Pharma Ltd Peer Comparison

Shows key financial metrics for the company and its peers

This section compares OneSource Specialty Pharma Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate OneSource Specialty Pharma Ltd's relative performance and valuation against major competitors.

Stock Name Astrazeneca Pharma India Ltd ₹8117.50 (+0.04%) M. Cap (Cr) 202.94 1 Yr Return (%) -12.61% P/E (TTM) 108.22 PB Ratio 23.25

Stock Name ERIS Lifesciences Ltd ₹1431.20 (+0.08%) M. Cap (Cr) 198.33 1 Yr Return (%) -17.33% P/E (TTM) 32.01 PB Ratio 5.08

Stock Name Caplin Point Laboratories Ltd ₹2583.60 (-1.44%) M. Cap (Cr) 196.38 1 Yr Return (%) +27.18% P/E (TTM) 30.63 PB Ratio 5.48

Stock Name OneSource Specialty Pharma Ltd ₹1626.90 (+0.07%) M. Cap (Cr) 186.52 1 Yr Return (%) NaN% P/E (TTM) -252.78 PB Ratio 3.20

Stock Name Natco Pharma Ltd ₹984.10 (+2.34%) M. Cap (Cr) 176.26 1 Yr Return (%) -3.31% P/E (TTM) 12.43 PB Ratio 1.91

Stock Name Cohance Lifesciences Ltd ₹451.90 (+2.67%) M. Cap (Cr) 172.88 1 Yr Return (%) -54.37% P/E (TTM) 96.46 PB Ratio 4.42

Stock Name Syngene International Ltd ₹420.35 (+1.19%) M. Cap (Cr) 169.68 1 Yr Return (%) -34.24% P/E (TTM) 53.58 PB Ratio 3.51

OneSource Specialty Pharma Ltd Cash Flow

Cash flow data provides a view of how money is generated and spent by OneSource Specialty Pharma Ltd, across its operating activities, investing activities, and financing activities.

PARTICULARS Operating Activities Mar 2026 55.18 Mar 2025 -47.28 Mar 2024 -107.21 Mar 2023 -162.88 Mar 2022 -415.89

PARTICULARS Investing Activities Mar 2026 -477.60 Mar 2025 -300.04 Mar 2024 510.54 Mar 2023 -67.72 Mar 2022 -691.60

PARTICULARS Financing Activities Mar 2026 361.06 Mar 2025 417.22 Mar 2024 -390.54 Mar 2023 118.32 Mar 2022 1161.96

PARTICULARS Net Cash Flow Mar 2026 -61.37 Mar 2025 69.90 Mar 2024 12.79 Mar 2023 -112.28 Mar 2022 54.47

OneSource Specialty Pharma Ltd Shareholding Pattern

This shows the ownership breakdown of OneSource Specialty Pharma Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.

Promoter 30.48%

Public 31.4%

Other Institutions 10.48%

FII 17.5%

Mutual Funds 10.13%

About OneSource Specialty Pharma Ltd

Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of `Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The Company name was then changed to `Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies. The status of the Company was then converted from a Private Limited Company to a Public Limited Company, and renamed as `Stelis Biopharma Limited' dated July 31, 2021,. Subsequently, the name was changed to its present `Onesource Specialty Pharma Limited' on February 13, 2024, and a fresh Certificate of Incorporation dated February 13, 2024, was issued by the Registrar of Companies, Karnataka at Bangalore.In FY 2024-25, a Scheme of Arrangement amongst Strides Pharma Science Limited, Steriscience Specialties Private Limited and the Company and their respective shareholders and creditors was implemented on November 14, 2024. Prior to the Scheme of Arrangement, Strides Pharma Science Limited, Steriscience Specialties Private Limited were involved in the businesses of biologics and DDC, soft gelatin capsule and injectables business, respectively. Pursuant to the Scheme, Strides Pharma Science Limited, Steriscience Specialties Private Limited got transferred / demerged to and vested with the Company as a going concern effective on April 1, 2024 and the Scheme was made effective from November 27, 2024 with the Registrar of Companies. In accordance with the Scheme of Arrangement, 11,44,36,021 Equity Shares of Re. 1/- each have been allotted and issued. At present, Company is engaged in the research, development, manufacture and commercialisation of biological drug products in various injectable formats. It also offers end-to-end Contract Development and Manufacturing Operations (CDMO) services across all phases of pre-clinical and clinical development and commercial supply of biologics. Company has 5 globally compliant Manufacturing Facilities. Customer list includes some of the top pharmaceutical generic companies, innovator pharmaceutical and biopharmaceutical companies, small biotechs and dedicated R&D houses, spread across the globe.Company completed execution of high-value projects across Biologics, Injectables, and Oral Technologies in FY 2025.

Chairman & Non Executive Dir.

Arun Kumar

Registered office 201 Devarata Sector 17 Vashi, Navi Mumbai Sanpada, Thane, Maharashtra, 400703

FAX :91-22-2789 2924/78929 08076

Background

Incorporation Year 2007

Face Value ₹1.00

Market Lot 1

OneSource Specialty Pharma Ltd Latest News

VIEW MORE NEWS

FAQs on OneSource Specialty Pharma Ltd